SRPT

Sarepta Therapeutics INC

+$183.6M

Net Activity

Institutions Holding

344

Popularity Rank

#1707

Avg Weight

0.04%

Total Value

$2.4B

Ownership Trend

344 institutions currently hold SRPT, with 148 net buyers and 189 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

189

Net Buying Institutions

148

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$321.1M
VP
Vanguard Portfolio Management LLC
$144.5M
SS
State Street CORP
$143.9M
AC
Aqr Capital Management LLC
$138.6M
TS
Two Sigma Investments, LP
$99.9M

Top 5 by Conviction

RC
Ra Capital Management, L.p.
0.90%
6C
683 Capital Management, LLC
0.85%
EA
Erste Asset Management GmbH
0.57%
VC
Voleon Capital Management LP
0.38%
CW
C WorldWide Group Holding A/S
0.23%
View all 344 holding institutions

Quarterly Activity

Recent Activity

+$1.6B

Total Buy Value

$774.7M

Total Sell Value

New buy37
Trim134
Add111
Sold out55

148

Net Buyers

189

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding SAREPTA THERAPEUTICS INC (SRPT)?
Major stakeholders currently include BlackRock, Inc. ($321.1M), Vanguard Portfolio Management LLC ($144.5M), State Street CORP ($143.9M). Based on the latest 13F filings, there are a total of 344 tracked investment funds and institutions maintaining positions in SRPT.
What is the overall institutional sentiment toward SRPT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $183.6M, driven by 148 managers accumulating shares while 189 reduced their exposure.
Which institutions have been selling or reducing their SRPT positions?
In the latest period, 134 funds trimmed their holdings, and 55 managers completely exited their positions. The aggregate reported sell value was $774.7M.
Are there any notable investors adding SRPT to their portfolios?
Yes, buying activity remains notable. 37 institutions opened new positions in {ticker}, and 111 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.6B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

312 institutions currently hold both SRPT and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

319 institutions currently hold both SRPT and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

309 institutions currently hold both SRPT and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail